Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1527232/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850158507506008064 |
|---|---|
| author | Chenghao Fu Chenghao Fu Haonan Du Qiang Wang Weiyou Zhu Guangli Bian Zhujuan Zhong Yuheng Wang Lei Cao |
| author_facet | Chenghao Fu Chenghao Fu Haonan Du Qiang Wang Weiyou Zhu Guangli Bian Zhujuan Zhong Yuheng Wang Lei Cao |
| author_sort | Chenghao Fu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-770fc02317c6488fb25f7b09197af0bc |
| institution | OA Journals |
| issn | 1664-3224 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-770fc02317c6488fb25f7b09197af0bc2025-08-20T02:23:51ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-11-011510.3389/fimmu.2024.15272321527232Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with AnlotinibChenghao Fu0Chenghao Fu1Haonan Du2Qiang Wang3Weiyou Zhu4Guangli Bian5Zhujuan Zhong6Yuheng Wang7Lei Cao8Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Thoracic Surgery, Taizhou Fourth People’s Hospital, Taizhou, Jiangsu, ChinaDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Radiology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, ChinaDepartment of Pathology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Oncology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2024.1527232/fulltail effectimmunotherapycancer therapyPSCICISintilimab |
| spellingShingle | Chenghao Fu Chenghao Fu Haonan Du Qiang Wang Weiyou Zhu Guangli Bian Zhujuan Zhong Yuheng Wang Lei Cao Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib Frontiers in Immunology tail effect immunotherapy cancer therapy PSC ICI Sintilimab |
| title | Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib |
| title_full | Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib |
| title_fullStr | Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib |
| title_full_unstemmed | Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib |
| title_short | Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib |
| title_sort | corrigendum case report a golden tail of immunotherapy significant tail effect in a chemotherapy resistant advanced pulmonary sarcomatoid carcinoma patient treated by sintilimab combined with anlotinib |
| topic | tail effect immunotherapy cancer therapy PSC ICI Sintilimab |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1527232/full |
| work_keys_str_mv | AT chenghaofu corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT chenghaofu corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT haonandu corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT qiangwang corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT weiyouzhu corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT guanglibian corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT zhujuanzhong corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT yuhengwang corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib AT leicao corrigendumcasereportagoldentailofimmunotherapysignificanttaileffectinachemotherapyresistantadvancedpulmonarysarcomatoidcarcinomapatienttreatedbysintilimabcombinedwithanlotinib |